Privia Health Group, Inc. — Form 8-K
Filed August 6, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 58/100
What the filing says
Privia Health reported Q2 2026 net income of $9.0M (+236.7% YoY) and Adjusted EBITDA of $37.4M (+29.1% YoY) on total revenue of $632.6M (+21.4% YoY). The company raised full-year 2026 guidance across all key metrics: Revenue to $2,350–$2,450M (high end), Adjusted EBITDA to $145–$155M (mid-to-high end), and attributed lives to 1,625,000–1,650,000. Implemented providers grew 10.1% YoY to 5,644; attributed lives grew 19.2% YoY to 1,647,000.
Why this rating
Strong organic growth and margin expansion; guidance raise is meaningful but incremental. Relative to $1.8B market cap, improvements are solid but not transformational; operating leverage evident but execution risk remains in regulated healthcare.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.